Skip to content

Beckwith Wiedemann Syndrome Due To Paternal Uniparental Disomy Of Chromosome 11 C5680249

Published: July 22, 2026Updated: August 20, 2026

A genetic overgrowth disorder caused by abnormal chromosome 11 imprinting. It affects infants and children, causing organ enlargement and increased tumor risk. Management involves regular screening and multidisciplinary care.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Neonatal hypoglycemia

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Macroglossia

(congenital)

Hemihyperplasia

(congenital)

Macrosomia

(congenital)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Intensive Tumor Surveillance Program

Comprehensive screening protocol with abdominal ultrasound every 3 months until age 7-8 years, AFP levels every 3 months until age 4 years, and clinical examinations to detect embryonal tumors associated with paternal UPD.

monitoring

Additional treatment options

Neonatal Abdominal Defect Management

Multidisciplinary management of omphalocele including possible silo placement, conservative wrapping for small defects, or staged surgical repair with pediatric surgery and neonatology coordination.

surgical

Hyperinsulinism Management

Treatment of neonatal hyperinsulinemic hypoglycemia with dextrose infusions, diazoxide, and potentially octreotide for severe cases unresponsive to standard therapies.

medication

Hemihyperplasia Orthopedic Management

Serial limb length assessment with planned orthopedic intervention such as epiphysiodesis, guided growth procedures, or lengthening surgeries to address leg length discrepancy.

surgical

Multidisciplinary Care Coordination

Integration of care across genetics, endocrinology, oncology, surgery, and developmental services to address the complex needs of patients with paternal UPD-related BWS through coordinated appointments and communication.

complementary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Beckwith Wiedemann Syndrome Due To Paternal Uniparental Disomy Of Chromosome 11 C5680249?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Weksberg R, Shuman C, Beckwith JB. Beckwith-Wiedemann syndrome and assisted reproductive technology: molecular and clinical insights. Hum Genet. 2020.

review2020
2

Choufani S, McGowan-Jordan J, Lemyre E, et al. Consensus statement on the management of Beckwith-Wiedemann syndrome. Nat Rev Endocrinol. 2022.

guideline2022
3

Mussa A, Ferrero GB, Calzi F, et al. Prospective surveillance for tumor development in Beckwith-Wiedemann syndrome patients: a multicenter cohort study. J Pediatr. 2021.

clinical_trial2021
4

Brioude F, Kalish JM, Mussa A, et al. Clinical and molecular diagnosis, screening and treatment of Beckwith-Wiedemann syndrome: an international consensus statement. Nat Rev Genet. 2023.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Beckwith Wiedemann Syndrome Due To Paternal Uniparental Disomy Of Chromosome 11 C5680249. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy